[1]
“Computational Drug Design For Rare And Neglected Diseases: A Systematic Review of Unused Opportunities”, Int. J. of Res. in Pharmacology &Pharmacotherapeutics , vol. 14, no. 2, pp. 463–472, Jun. 2025, doi: 10.61096/ijrpp.v14.iss2.2025.463-472.